Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02417818
Other study ID # 14-266-3
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2015
Est. completion date February 2023

Study information

Verified date February 2023
Source University Hospital Schleswig-Holstein
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In plastic and reconstructive surgery, treatment strategies of second-degree burns, superficial wounds, burn scars, flaps and chronic wounds aim at reducing infection and improving microcirculation. Although previous studies indicate that Plasma Therapy can accelerate wound healing, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of Plasma Therapy on second-degree burns, superficial wounds, burn scars, flaps and chronic wounds in a human in-vivo setting for the first time.


Recruitment information / eligibility

Status Completed
Enrollment 240
Est. completion date February 2023
Est. primary completion date February 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Group A (n=20): Consent-capable male and female patients =18 years of age who have sustained a second-degree burn on =1% and =30% of the surface of the body. Group B (n=20): Consent-capable male and female patients =18 years of age who require a skin excision for the purpose of a skin graft. The minimal size of the skin-graft donor site must not be less than 1% of TBSA. Group C (n=20): Consent-capable male and female patients =18 years of age suffering from a wound that has not yet healed =3 weeks. The minimal size of the wound site must not be less than 1% of TBSA. Group D (n=20): Consent-capable healthy male and female probands =18 years of age serving as sham group. None of the the criteria of groups A-C must be evident. No soft tissue injury must be evident. Group E (n=20): Consent-capable male and female patients =18 years of age who have sustained a second-degree burn on =1% and =30% of the surface of the body. Group F (n=20): Consent-capable male and female patients =18 years of age who require a skin excision for the purpose of a skin graft. The minimal size of the skin-graft donor site must not be less than 1% of TBSA. Group G (n=20): Consent-capable male and female patients =18 years of age suffering from a wound that has not yet healed =3 weeks. The minimal size of the wound site must not be less than 1% of TBSA. Group H (n=20): Consent-capable healthy male and female probands =18 years of age serving as sham group. None of the the criteria of groups E-G must be evident. No soft tissue injury must be evident. Group I (n=20): Consent-capable male and female patients =18 years of age suffering from a hypertrophic burn wound. Group J (n=20): Consent-capable male and female patients =18 years of age suffering from a hypertrophic burn wound. Group K (n=20): Consent-capable male and female patients =18 years of age received a flap. Group L (n=20): Consent-capable male and female patients =18 years of age received a flap. Exclusion Criteria: General exclusion criteria - below 18 years of age - wounds requiring artificial respiration, since consent for the study participation is unobtainable Exclusion criteria groups A, B, D, E, F, H: - peripheral arterial occlusive disease - vasculitis - diabetes mellitus - chronic kidney or liver disease - cardiac dysfunction - arterial hypo- or hypertension Anamnestic exclusion criteria - ongoing immunosuppressive or chemotherapy treatment - drug abuse - systemic skin diseases - systemic and local cortisone therapy

Study Design


Intervention

Device:
Plasma Therapy (PlasmaDerm)
Plasma Therapy (PlasmaDerm)
Repetitive Plasma Therapy (repetitive PlasmaDerm)
Repetitive Plasma Therapy (Repetitive PlasmaDerm)

Locations

Country Name City State
Germany University of Schleswig-Holstein Lübeck Schleswig-Holstein

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Schleswig-Holstein

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in microcirculation (composite measure) capillary blood flow [arbitrary units AU]
capillary blood velocity [AU]
tissue oxygen saturation [%]
relative postcapillary venous filling pressure [AU]
Baseline and 1 minute post-dose
Secondary Change in microcirculation (areolar measure) tissue oxygen saturation [%]
tissue hemoglobin index
Baseline, while and 1 minute post-dose
See also
  Status Clinical Trial Phase
Withdrawn NCT02241941 - Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury Phase 4
Completed NCT02210208 - A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients. N/A
Completed NCT05063409 - Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting N/A
Completed NCT03730688 - Non-invasive Limb Compartment Pressure Measurement N/A
Recruiting NCT04368117 - STAT: Standard Therapy Plus Active Therapy N/A
Terminated NCT01773083 - Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma Phase 3
Completed NCT02092701 - Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period N/A
Recruiting NCT06263296 - Smartphone Assisted Self-management Education for Adult Burn Patient at Aftercare N/A
Completed NCT02145130 - Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects Phase 1
Completed NCT01618630 - Amino Acid Supplementation in Recovery From Severe Burns N/A
Recruiting NCT05876442 - Efficacy of EPSW Plus HILT on Carpal Tunnel Syndrome Post Burn Injury N/A
Completed NCT04417439 - The Effect of Acute Phase Treatment Approaches on Creatine Kinase and the Musculoskeletal System in Different Types of Burns
Completed NCT02417805 - Cutaneous Microcirculation After Remote Ischemic Preconditioning N/A
Completed NCT02417779 - Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy N/A
Completed NCT01404026 - Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury N/A
Completed NCT03204669 - Trace Element Repletion Following Severe Burn Injury N/A
Recruiting NCT04947449 - Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors
Not yet recruiting NCT05532488 - Inulin in Burn-induced Insulin Resistance N/A
Recruiting NCT02189538 - Effect of n-3 PUFA From Fish in Enteral Nutrition of Major Burn Patients N/A
Completed NCT01795079 - Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury N/A